3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
200
Gastrointestinal
49
Breast
43
Thoracic
41
Head & Neck
37
Genitourinary
36
Dermatologic
19
Sarcoma
10
Lymphoid
7
CNS
7
Other solid neoplasm
5
Plasma cell
2
Other hematologic neoplasm
2
Other
2
Endocrine
2
Other neoplasm
1
Myeloid
1
Classical hematology
1
Conditions
Precancerous Conditions
10
Neoplasms
3
Keratosis, Actinic
3
Skin Diseases
2
Preleukemia
2
Obesity-Related Malignant Neoplasm
2
Neoplasms by Histologic Type
2
Myelodysplastic Syndromes
2
Leukemia, Myeloid, Acute
2
Leukemia, Biphenotypic, Acute
2
Leukemia
2
Immunoproliferative Disorders
2
Immune System Diseases
2
Hematologic Diseases
2
Endometrial Neoplasms
2
Bone Marrow Diseases
2
Venentoclax
1
Uterine Prolapse
1
Uterine Cervical Neoplasms
1
Syndrome
1
Stomach Neoplasms
1
Rectal Malignant Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pathologic Processes
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Neoplasms by Site
1
Multiple Myeloma
1
Metrorrhagia
1
Menstruation Disturbances
1
Interventions
Robotic Surgical Procedures
1
Hysterectomy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Uterine Cervical Neoplasms
×
Other neoplasm
×
90 days
×
Clear all
NCT07120945
2026-03-06
Embrace Gyn
Medtronic - MITG
Phase NA
Recruiting
70 enrolled